Hill Publishing Group | contact@hillpublisher.com

Hill Publishing Group

Location:Home / Journals / International Journal of Clinical and Experimental Medicine Research /

DOI:http://dx.doi.org/10.26855/ijcemr.2021.10.005

Research Progress of Traditional Chinese Medicine in the Treatment of Hypertension

Date: September 18,2021 |Hits: 257 Download PDF How to cite this paper

Xuan Hao, Junru Zhang*

1First Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, 712000, Shaanxi, China. 

2Department of Cardiology, Shaanxi Provincial Hospital of traditional Chinese Medicine, Xi’an 710000, Shaanxi, China.

*Corresponding author: Junru Zhang

Abstract

As one of the diseases with the highest incidence of chronic diseases in China, hypertension has an important impact on the living standards of our people.  The mortality rate of complications caused by hypertension is also increasing year by year, mainly the damage to the heart, brain, kidney and other important target organs, and its occurrence and development is related to a variety of factors.  Many risk factors are also the initiators of its development and progress.  The treatment of hypertension is not only to reduce blood pressure, but also to prevent and intervene the impact of its risk factors on the human body.  In recent years, with the deepening of research, the antihypertensive mechanism of some traditional Chinese medicine has been gradually discovered, which provides effective evidence for the treatment of hypertension with traditional Chinese medicine. To make traditional Chinese medicine more targeted and safe, this paper will elaborate on syndrome type analysis, syndrome treatment, target organ damage and traditional Chinese medicine in renin angiotensin aldosterone system (RAAS), inhibition of sympathetic nerve activity, inhibition of vascular remodeling, effect of calcium antagonist,  improvement of insulin resistance, diuresis and so on.

References

[1] 2018 Chinese guidelines for the management of hypertension [J]. Chinese Journal of Cardiovascular Medicine, 2019, 24(01): 24-56.

[2] Expert Consensus on Diagnosis and Treatment of Hypertension with Traditional Chinese Medicine [J]. Chinese Journal of Experimental Traditional Medical Formulae, 2019, 25(15): 217-221.

[3] LI Jing. (2018). Correlation between TCM Constitutions and Syndromes in 200 Patients with Hypertension [J]. Chinese Archives of Traditional Chinese Medicine, 2018, 36(12): 2907-2910.

[4] Cheng Lu. (2017). Study on TCM Syndrome Distribution and Blood Pressure Variability in 443 Patients with Primary Hypertension [J]. Chinese Journal of Information on TCM, 2017, 24(07): 19-22.

[5] Yangyang Yang. (2020). TONG Xiao-lin’s experience in the treatment of hypertension with ‘three phases and six states [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2020, 35(06): 2949-2953.

[6] Boli Zhang Mianhua Wu. (2017). Internal Medicine [M]. Beijing: People’s Medical Publishing House, 2017: 114-127.

[7] Kang Ding. (2015). Clinical study of Qianyang Yuyin granule in the treatment of Hypertension (Yin deficiency and Yang hyperactivity) [J]. Lishizhen Medicine and Materia Medica Research, 2015, 26(05): 1149-1150.

[8] Yiqun Song. (2016). Effect Observation of Jiawei Qiju Dihuang Decoction Combined with Western Medicine Treatment of Hypertension of Hyperactivity of Yang Due to Yin Deficiency [J]. Liaoning Journal of Traditional Chinese Medicine, 2016, 43(02): 296-298.

[9] Jiaxin Wang. (2019). Clinical observation of Pinggan Ziyin Tongyu recipe combined with amlodipine besylate in the treatment of hypertension [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(02): 205-211.

[10] Ping Gu. (2016). Zhengan Xifeng Decoction Treating Plasma Metabonomics of Yin Deficiency and Yang Hyperactivity Type of Hypertension [J]. Liaoning Journal of Traditional Chinese Medicine, 2016, 43(07): 1353-1355.

[11] Bairong Du. (2021). Study on the Therapeutic effect and Mechanism of Liuwei Dihuang Pill in the treatment of Hypertension with liver and Kidney Yin deficiency [J/OL]. Journal of Chinese Medicinal Materials, 2021(06): 1509-1513 [2021-08-02].

[12] Chunliang Wang. (2020). Clinical Study on Dihuang Yinzi Capsules Combined with Western Routine Therapy for Treatment of Resistant Hypertension with Yin-yang Deficiency Syndrome [J]. Chinese Journal of Information on Traditional Chinese Medicine, 2020, 27(12): 21-25.

[13] Ziming Zhao. (2019). Study on Clinical Efficacy and Safety of Compound Qi Ma Capsule and Western Medicine Treatment of Hypertension Patients with Qi Deficiency and Turbid Phlegm Syndrome [J]. Traditional Chinese Drug Research and Clinical Pharmacology, 2019, 30(07): 879-884.

[14] Hongye Wang. (2021). Clinical Efficacy and Safety of Yishen Huoxue Decoction Combined with Balanced Acupuncture in Treatment of Essential Hypertension [J]. Chinese Archives of Traditional Chinese Medicine, 2021, 39(02): 235-238.

[15] Wei Jia. (2015). Thinking on choosing hypotensor in individual therapy for hypertension based on TCM syndrome differentiation [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2015, 30(07): 2422-2424.

[16] Jing Xie. (2018). Relationship between TCM Syndrome Type and Left Ventricular Geometry in Hypertension [J]. Journal of Basic Chinese Medicine, 2018, 24(08): 1098-1100+1112.

[17] Shihua Luo. (2017). Effect and Safety of TCM treatment according to Syndrome Differentiation combined with ACEIs in Left Ventricular Hypertrophy in Hypertensive Patients: A Systematic Review [J]. Chinese Archives of Traditional Chinese Medicine, 2017, 35(06): 1410-1416.

[18] Xiaoyun Cui. (2018). Clinical study on treatment of hypertensive left ventricular diastolic dysfunction by Yiqi Huoxue Bushen Jiangya Formula [J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2018, 33(03): 1152-1155.

[19] Zhi Ji. (2019). Effect of electroacupuncture on Myocardial hypertrophy in spontaneously hypertensive Rats [J]. Journal of Traditional Chinese Medicin, 2019, 60(05): 427-432.

[20] Report on Nutrition and chronic Diseases of Chinese residents (2020) [J]. Acta Nutrimenta Sinica, 2020, 42(06): 521.

[21] Weifeng Cui. (2018). Effect of Jiangya Bao Series prescription on Cardiovascular and Cerebrovascular risk in the treatment of essential Hypertension [J]. Chinese Journal of Gerontology, 2018, 38(17): 4097-4099.

[22] Caiyu Pan. (2019). Clinical Efficacy of Huanyu Ditan Linao Decoction Combined with Vinpocetine Tablets in Treatment of Elderly Hypertensive Cerebral Hemorrhage [J]. Chinese Archives of Traditional Chinese Medicine, 2019, 37(03): 746-750.

[23] Chuangchang Wang. (2021). Clinical efficacy of Bushen Yixin tablet in the treatment of early Renal damage in patients with Kidney Yang deficiency essential Hypertension and its effect on Renal Fibrosis Factor [J]. Journal of Traditional Chinese Medicin, 2021, 62(10): 874-880.

[24] Jiangmin Du. (2018). Application of Urinary Microprotein in Diagnosis of Early Renal Injury of Essential Hypertension and Evaluation of Therapeutic Effect of Yishen Pinggan Decoction [J]. Chinese Archives of Traditional Chinese Medicine, 2018, 36(02): 492-495.

[25] Jiafeng Lu. (2020). Regularity of traditional Chinese Medicine prescription for different Syndromes of hypertensive Nephropathy [J]. Chinese Traditional Patent Medicine, 2020, 42(03): 813-816.

[26] Dong Deng. (2017). Research progress on mechanisms of Chinese materia medica in treatment of hypertension [J]. Chinese Traditional and Herbal Drugs, 2017, 48(21): 4565-4570.

[27] Lihong Wang. (2018). Effects of angelica volatile oil on renin and angiotensin Ⅱ in spontaneously hypertensive rats [J]. West China Journal of Pharmaceutical Sciences, 2018, 33(03): 251-254.

[28] Lijie Yu. (2016). Effects of Dahuang—mahuang formula on blood pressure and plasma renin—angiotensin system in rats [J]. Hebei Journal of Traditional Chinese Medicine, 2016, 38(11): 1683-1687.

[29] Haining Gan. (2016). Effect of Compound Qima Capsule on Blood Pressure and Renin—Angiotensin—Aldoster System in Renal Hypertensive Rats [J]. Chinese Archives of Traditional Chinese Medicine, 2016, 34(07): 1746-1748.

[30] Zeming Ren. (2019). Antihypertensive Effect and Mechanism of Fresh Dendrobium Officinale on Spontaneously Hypertensive Rats [J]. Chinese Journal of Modern Applied Pharmacy, 2019, 36(15): 1865-1869.

[31] Meifang Xiao. (2007). Effects of “Huoxue Qianyang Granule” on Renin-Angiotensin System in Plasma of Spontaneous Hypertensive Rats [J]. Shanghai Journal of Traditional Chinese Medicine, 2007(07): 59-61.

[32] Bo Ma. (2011). Research Progress on antihypertensive effect and Mechanism of Uncaria Uncaria [J]. China Medical Herald, 2011, 8(07): 12-14.

[33] Hui Chai. (2018). Effect of Dilong Jiangya capsule on renaminase expression in spontaneously hypertensive rats [J]. Journal of Clinical Cardiology, 2018, 34(01): 66-69.

[34] Jiao Mei. (2018). Progress of Eucommia Ulmoides In Treatment of Hypertension, 2018, 18(81): 35-36.

[35] Dai Nan. (2018). Effect of Modified Tianma Gouteng Drink on Vascular Endothelial Dysfunction and Nerve Factor for SHR Model Rats [J]. Journal of Sichuan of Traditional Chinese Medicine, 2018, 36(09): 44-47.

[36] Xin Xie. (2018). Effect of Zhengan Xifeng Decoction on Apoptosis of Aortic Arch Vascular Smooth Muscle Cells in Spontaneously Hypertensive Rats [J]. Chinese Archives of Traditional Chinese Medicine, 2018, 36(06): 1424-1427.

[37] Zuoyu Wang. (2008). Effect of compound Evonymus alata and Uncaria rhynchophylla decoction on L—type calcium channels in rats with cardiac hypertrophy [J]. Medical Journal of the Chinese People’s Armed Police Force, 2008(07): 611-614.

[38] Jie Zhang. (2005). Effect of Danshensu on calcium-activated potassium channel in cultured porcine coronary artery smooth muscle cells [J]. Basic & Clinical Medicine, 2005(11): 1054-1057.

[39] Wanlong Zhang. (2012). Mechanism of Zexie Decoction on Hypertension Due to High Salt Diet in Rat [J]. World Chinese Medicine, 2012, 7(06): 547-551.

[40] You Mee Ahn, et al. (2012). Oryeongsan (Wulingsan), a traditional Chinese herbal medicine, induces natriuresis and diuresis along with an inhibition of the rennin-angiotensin-aldosterone system in rats [J]. Journal of Ethnopharmacology, 2012, 141(3): 780-785.

[41] Yuhui Zhao. (2014). Research progress on chemical constituents and diuretic mechanism of diuretics Poria cocos, Poria cocos skin, Polyporus umbellatus and alisma orientalis [J]. Chinese Journal of Pharmacology and Toxicology, 2014, 28(04): 594-599.

[42] Ling Wang, et al. (2003). Chinese Medicine, Jiang-Tang-Ke-Li, Improves Insulin Resistance by Modulating Muscle Fiber Composition and Muscle Tumor Necrosis Factor-α in Fructose-Fed Rats [J]. 2003, 26(7): 527-532.

[43] Xuguang Hu, et al. (2014). The Chinese herbal medicine FTZ attenuates insulin resistance via IRS1 and PI3K in vitro and in rats with metabolic syndrome [J]. 2014, 12(1): 47.

[44] Yanbo Sui. (2011). The Intervention effect of Huanglian Wendan decoction on NF- κB, PPARα and glycolipids Metabolism in Metabolic Syndrome Rats [D]. Heilongjiang University of Chinese Medicine, 2011.

How to cite this paper

Research Progress of Traditional Chinese Medicine in the Treatment of Hypertension

How to cite this paper: Xuan Hao, Junru Zhang. (2021) Research Progress of Traditional Chinese Medicine in the Treatment of Hypertension. International Journal of Clinical and Experimental Medicine Research5(4), 451-456.

DOI: http://dx.doi.org/10.26855/ijcemr.2021.10.005

Volumes & Issues

Free HPG Newsletters

Add your e-mail address to receive free newsletters from Hill Publishing Group.

Contact us

Hill Publishing Group

8825 53rd Ave

Elmhurst, NY 11373, USA

E-mail: contact@hillpublisher.com

Copyright © 2019 Hill Publishing Group Inc. All Rights Reserved.